We are a clinical biopharmaceutical company developing MET-097i as an injectable treatment for obesity in a Phase I/Phase 2 clinical trial with overweight or obese healthy volunteers. (Incorporated in Delaware) We are developing next-generation injectable and oral nutrient stimulated hormone, or NuSH, analog peptides to treat obesity, overweight and related conditions. Obesity and overweight are […]

(Incorporated in Delaware) We specialize in the upfront design, testing, manufacturing, and sale of mission-critical systems for existing and emerging missile and defense, and space programs. Our integrated payload protection, propulsion, and interstage system solutions are deployed across a wide variety of existing and emerging programs supporting important Department of Defense (“DoD”) and space sector […]

We provide enterprises with customized identity security software. (Incorporated in Delaware) We offer a range of solutions to meet the varied needs of our customers across multiple deployment options, including Identity Security Cloud, our SaaS-based cloud solution built on our unified platform, Atlas, and IdentityIQ, our customer-hosted identity security solution. These solutions are designed to […]

We are a blank check company, incorporated in 2024, with a focus on the technology sector, specifically semiconductors and systems solutions. (Incorporated in the Cayman Islands) Initially, we will look at companies that are poised for growth, led by a highly regarded management team, with an enterprise value in the range of $200 million to […]

We are a blank check company. (Incorporated in the Cayman Islands) Our efforts to identify a prospective target business will not be limited to a particular industry or geographic location. We do not have any specific business combination under consideration.  As a blank check company incorporated for the purpose of effecting a business combination, we […]

Ascentage Pharma Group International, or Ascentage Pharma, is offering 7,325,000 American depositary shares, or ADSs. Each ADS represents four ordinary shares. Note: This is our initial public offering in the United States, and no public market currently exists for the ADSs. Our ordinary shares, par value US$0.0001 per share, have been listed on The Stock Exchange […]

Titan America is a leading vertically integrated, multi-regional manufacturer and supplier of heavy building materials and services operating primarily on the Eastern Seaboard of the United States (the “Eastern Seaboard”). (Incorporated in Belgium) We are a leading provider of materials that contribute to lower carbon emissions than traditional building materials and/or beneficial reuse of waste […]

(Incorporated in Delaware)  We are a commercial-stage medical device company engaged in the design, development and commercialization of innovative solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing advanced adaptive closed-loop algorithms to simplify and improve the treatment of their disease. Diabetes is a serious, chronic and […]

  We are a clinical-stage biopharmaceutical company harnessing the power of human genetics to develop novel, small molecule precision medicines for patients living with renal, cardiovascular and related metabolic diseases, including obesity. (Incorporated in Delaware) We are advancing a pipeline using our Compass platform, which allows us to identify and characterize genetic variants in disease […]

In Japan, we are a holding company that through our subsidiaries, owns and operates a real estate renovation and resale company (with subsidiaries including construction companies, building material manufacturers, and building materials trading companies), a real estate development company (with subsidiaries including building management companies and design offices), a hotel management company, and a restaurant […]